Literature DB >> 31710391

Bridging the gaps: More inclusive research needed to fully understand Parkinson's disease.

Rebecca M Gilbert1, David G Standaert2.   

Abstract

Entities:  

Keywords:  diversity; underrepresented populations

Mesh：

Year:  2019        PMID： 31710391     DOI： 10.1002/mds.27906

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  6 in total

1.  Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.

Authors:  Roseanne D Dobkin; Ninad Amondikar; Catherine Kopil; Chelsea Caspell-Garcia; Ethan Brown; Lana M Chahine; Connie Marras; Nabila Dahodwala; Sneha Mantri; David G Standaert; Marissa Dean; Ira Shoulson; Kenneth Marek; Andrea Katz; Monica Korell; Lindsey Riley; Caroline M Tanner
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

2.  Associations between exercise classes and self-reported exercise by people with Parkinson's disease at Parkinson's foundation centers of excellence.

Authors:  Ella Nettnin; Stephanie Burrows; Guanhong Miao; Samuel S Wu; David K Simon; Miriam R Rafferty
Journal:  Clin Park Relat Disord       Date:  2022-02-15

Review 3.  Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.

Authors:  Pedro Magalhães; Hilal A Lashuel
Journal:  NPJ Parkinsons Dis       Date:  2022-07-22

4.  Network metrics, structural dynamics and density functional theory calculations identified a novel Ursodeoxycholic Acid derivative against therapeutic target Parkin for Parkinson's disease.

Authors:  Aniket Naha; Sanjukta Banerjee; Reetika Debroy; Soumya Basu; Gayathri Ashok; P Priyamvada; Hithesh Kumar; A R Preethi; Harpreet Singh; Anand Anbarasu; Sudha Ramaiah
Journal:  Comput Struct Biotechnol J       Date:  2022-08-10       Impact factor: 6.155

5.  Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.

Authors:  Charity G Patterson; Elizabeth Joslin; Alexandra B Gil; Wendy Spigle; Todd Nemet; Lana Chahine; Cory L Christiansen; Ed Melanson; Wendy M Kohrt; Martina Mancini; Deborah Josbeno; Katherine Balfany; Garett Griffith; Mac Kenzie Dunlap; Guillaume Lamotte; Erin Suttman; Danielle Larson; Chantale Branson; Kathleen E McKee; Li Goelz; Cynthia Poon; Barbara Tilley; Un Jung Kang; Malú Gámez Tansey; Nijee Luthra; Caroline M Tanner; Jacob M Haus; Giamila Fantuzzi; Nikolaus R McFarland; Paulina Gonzalez-Latapi; Tatiana Foroud; Robert Motl; Michael A Schwarzschild; Tanya Simuni; Kenneth Marek; Anna Naito; Codrin Lungu; Daniel M Corcos
Journal:  Trials       Date:  2022-10-06       Impact factor: 2.728

6.  Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person.

Authors:  Lana M Chahine; Iris Chin; Chelsea Caspell-Garcia; David G Standaert; Ethan Brown; Luba Smolensky; Vanessa Arnedo; Daisy Daeschler; Lindsey Riley; Monica Korell; Roseanne Dobkin; Ninad Amondikar; Stephen Gradinscak; Ira Shoulson; Marissa Dean; Kevin Kwok; Paul Cannon; Kenneth Marek; Catherine Kopil; Caroline M Tanner; Connie Marras
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.520
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.